Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

RWJ-26819: Non-steroidal progestin agonist from R.W. Johnson

July 12, 1996

U.K. and Canadian approval sought for Alora

July 12, 1996

New formulation of rhGH from Alkermes and Genentech

July 12, 1996

KGR-1380: A novel glycation inhibitor

July 12, 1996

Aldose reductase inhibitors described by Grelan

July 12, 1996

Optro enters U.S./Canadian phase II trials

July 12, 1996

Pharmacia & Upjohn terminates Hemopure codevelopment agreement

July 12, 1996

Results of fat accumulation/PAI-1 levels relationship study disclosed

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

(+)-Sch-58053: Schering-Plough's cholesterol absorption inhibitor

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...